Mayer Brown represented Spearhead Integrated Marketing Communication Group on the acquisition of all shares in Smaato Holding AG from more than 30 sellers situated in the USA, Asia and Europe for a purchase price of up to US$ 148 million.
Vinge has advised Bygghemma Sverige AB in connection with the acquisition of Stonefactory Scandinavia AB. Bygghemma is the leading e-commerce home improvement and home furnishing company in the Nordic region. Stonefactory is the leading e-commerce company in Sweden within tile, clinker and natural stone.
Kristian Ford is advising Bygghemma together with Henrik Jonsson.
De Brauw advises IMCD on the acquisition of Turkish speciality chemical distributor Feza Kimya.
Client name
IMCD N.V. - purchaser
Nature of transaction
Slaughter and May advised GoDaddy on its acquisition of Host Europe Group (HEG) from the private equity firm Cinven for €1.69 billion, including €605 paid to the selling shareholders and €1.08 billion in assumed net debt.
Herbert Smith Freehills has advised new client Claris Lifesciences Limited on the sale of its global generic injectables business Claris Injectables for US$625 million to Baxter International Inc..
Claris Injectables, a wholly-owned subsidiary of listed Indian pharmaceutical company Claris Lifesciences Limited based in India, is a global generic injectables pharmaceutical company with its market presence across the world and a successful 15-year history.
DLA Piper has advised Bank of Queensland (ASX: BOQ) on its AU$20 million acquisition of Centrepoint Alliance Limited's Premium Funding business.
Centrepoint Alliance Limited (ASX: CAF) is an Australian network of non-institutional advisers and brokers in financial services. Their Premium Funding division is a leader in business insurance premium funding, originating around 30,000 new loans a year.
Bank of Queensland (BOQ) will acquire 100 per cent of the business, which will form a new division within BOQ Finance.
Kuros Biosciences Ltd. (SIX:KURN) announced the signing of a combination agreement with Xpand Biotechnology B.V. with the intention to acquire Xpand by way of an exchange of all Xpand shares for up to 2.105 million new Kuros shares, subject to customary conditions. Xpand's novel orthobiologic MagnetOs was approved for sale in the European Union in July 2016 and is under regulatory review in the US. VISCHER is advising Kuros; the team is led by Matthias Staehelin with Gian-Andrea Caprez, Angelo Imperiale and Angela Oppliger (all Corporate).
Hogan Lovells, White & Case and Luther provide legal advice for Open Grid Europe and Gasunie's takeover of jordgasTransport from Statoil
Houthoff Buruma advised investment firm H2 Equity Partners on the acquisition of an interest in fixed base flight simulator producer Multi Pilot Simulations B.V. The company has its head office in the Netherlands with a production location in Germany. H2 will support the existing MPS management team in its growth plans.
Houthoff Buruma team included: Josephine de Bok , Anouk Boutens , Jan Brölmann , Philip van der Eijk , Sanne Houdijk , Bas Kentie , Gerard van der Linden , Bram Caudri, Michiel Pannekoek , Fleur Tuinzing-Westerhuis , Annemiek Wassink
On December 15, 2016, Lonza Group AG (Lonza) announced that it entered into a definite agreement under which Lonza will acquire Capsugel S.A. (Capsugel) from Kohlberg Kravis Roberts & Co. L.P. (KKR), for USD 5.5 bn in cash, including refinancing of existing Capsugel debt of approximately USD 2 bn. The acquisition will be financed with a combination of debt and equity financing.